PULMONX CORPORATION (LUNG) Total liabilities 2019–2025
PULMONX CORPORATION (LUNG) total liabilities at each fiscal year-end, per SEC filings.
$75.2MFY2025 · since FY2019: $35.6M → $75.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.2M | -2.4% |
| FY2024 | $77.0M | +29.6% |
| FY2023 | $59.5M | +49.9% |
| FY2022 | $39.7M | -5.4% |
| FY2021 | $41.9M | +11.6% |
| FY2020 | $37.6M | +5.6% |
| FY2019 | $35.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice